Young HIV-positive women will wait longer to access the powerful DTG antiviral drug.
DTG (Dolutegravir) is the preferred first-line ARV in Kenya, but not recommended for women aged 15-49 because it can deform the spines of unborn babies. Read More
Let's stay in touch. Subscribe to our blog and get our best content in your inbox.